Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Vertex Pharmaceuticals Incorporated (VRTX)

185.76   2.7 (1.47%) 02-22 16:00
Open: 184.33 Pre. Close: 183.06
High: 185.84 Low: 182.94
Volume: 1,027,434 Market Cap: 47491M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 186.013 - 186.914 186.914 - 187.693
Low: 180.769 - 181.816 181.816 - 182.72
Close: 184.187 - 185.815 185.815 - 187.222

Technical analysis

as of: 2019-02-22 4:48:23 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 220.94     One year: 228.71
Support: Support1: 178.40    Support2: 148.43
Resistance: Resistance1: 189.16    Resistance2: 195.81
Pivot: 185.24
Moving Average: MA(5): 186.32     MA(20): 186.02
MA(100): 177.53     MA(250): 171.04
MACD: MACD(12,26): 1.10     Signal(9): 1.58
Stochastic oscillator: %K(14,3): 48.89     %D(3): 54.37
RSI: RSI(14): 52.43
52-week: High: 195.81  Low: 144.07  Change(%): 12.0
Average Vol(K): 3-Month: 152657  10-Days: 128421

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
VRTX has closed below upper band by 45.7%. Bollinger Bands are 51.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to VRTX's normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 22 Feb 2019 16:34:54 Z
The Zacks Analyst Blog Highlights: Nike, 3M, Vertex, PepsiCo and Verisk

Thu, 21 Feb 2019 21:07:54 Z
Top Stock Reports for Nike, 3M & Vertex

Thu, 21 Feb 2019 17:19:21 Z
The Zacks Analyst Blog Highlights: Intercept, Gilead, Vertex, Alkermes and Clovis

Wed, 20 Feb 2019 17:19:31 Z
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sun, 17 Feb 2019 16:08:05 Z
3 Most Profitable Drugmakers in the S&P 500 -- Are They Buys?

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 255.56
Shares Float (M) 253.29
% Held by Insiders
% Held by Institutions 154.60
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS 2.920
EPS Est. Current Year 1.630
EPS Est. Next Year 2.890
EPS Est. Next Quarter 0.560
Forward EPS 4.511
Book Value (p.s.) 10.600
PEG Ratio 0.80
Profit Margin 69.37
Operating Margin 21.79
Return on Assets (ttm) 43.5
Return on Equity (ttm) 65.8
Qtrly Rev. Growth 33.5
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 1440.00
Operating Cash Flow (M) 1270.00
Levered Free Cash Flow (M) 906.77

Stock Valuations

P/E 63.62
P/E Growth Ratio 0.01
P/BV 17.52
P/S 3964223744.00
P/CF 37.38

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.